« FDA Tells Sanofi to Take a Hike on Acomplia; Champagne Corks Popping at GSK | Main | DrugWonks and Michael Moore: Who's 'Demagoging' Who? »

June 18, 2007

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d834519bc269e200e008c781068834

Listed below are links to weblogs that reference The NAD Takes Another Swipe at Big Pharma -- This Time Bayer Gets Hurt:

Comments

cheap aion power leveling

Although Bayer did indeed have a survey showing docs preferred Aleve, the survey didn't define "preferred."

The comments to this entry are closed.

 
© 2010 Brandweek. All rights reserved. Terms Of Use and Privacy Policy Additional Terms Of Use and Privacy Policy.